Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva rises on mixed-bag Q4, sets 2022 guidance - Drug Delivery Business
Teva gains on earnings beat
Why Teva Pharmaceuticals Stock Has Two A-Products In The Bag (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals on LinkedIn: #quarterlyresults #earnings #tevapharm
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva Pharmaceutical revenue 2006-2022 | Statista
Teva Pharmaceutical says 48 states have agreed to its opioid settlement (NYSE:TEVA) | Seeking Alpha
Why Teva Pharmaceuticals Has Significant Upside (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical Industries Limited 2022 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations - Simply Wall St News
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical Stock Dives Despite a Better-Than-Expected Earnings Report | Barron's
Teva Pharmaceutical Is in Recovery - WSJ
Earnings Preview: What To Expect From Teva On Thursday
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
